Product Images Apidra Solostar

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 27 images provide visual information about the product associated with Apidra Solostar NDC 0088-2502 by Sanofi-aventis U.s. Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - apidra 01

Chemical Structure - apidra 01

Figure 1A - apidra 02

Figure 1A - apidra 02

Figure 1B - apidra 03

Figure 1B - apidra 03

This text appears to be a chart related to glucose levels measured in mg/dL along with the time in hours. It also mentions APDRA and REGULAR, but it's not clear what they refer to.*

Figure 1C - apidra 04

Figure 1C - apidra 04

The text provides glucose levels in mg/dL and mentions the terms aPDRA, post and REGULAR, pre. It also contains a graph with time in hours on the x-axis and glucose levels on the y-axis. However, the text is not sufficient to provide a complete description.*

Image - apidra 05

Image - apidra 05

Figure 2 - apidra 06

Figure 2 - apidra 06

Figure 3 - apidra 07

Figure 3 - apidra 07

This is a table that shows the insulin types "GLusine" and "Regular" with corresponding time intervals of 20 to 40 minutes. The text also mentions "INSULIN" at the top.*

Figure 4 - apidra 08

Figure 4 - apidra 08

Figure - apidra 09

Figure - apidra 09

Figure - apidra 10

Figure - apidra 10

Figure - apidra 11

Figure - apidra 11

Figure - apidra 12

Figure - apidra 12

Figure - apidra 13

Figure - apidra 13

Figure - apidra 14

Figure - apidra 14

Figure - apidra 15

Figure - apidra 15

Figure - apidra 16

Figure - apidra 16

Figure - apidra 17

Figure - apidra 17

This appears to be a physical description and diagram of a pen for injecting insulin. The diagram includes a protective seal, insulin reservoir with a window, outer and inner needle cap, dosage selector button, and rubber seal. The pen also indicates that it is designed to be used with pen needles, but these are not included in the package.*

Figure - apidra 18

Figure - apidra 18

Figure - apidra 19

Figure - apidra 19

Figure - apidra 20

Figure - apidra 20

Figure - apidra 21

Figure - apidra 21

Figure - apidra 22

Figure - apidra 22

Figure - apidra 23

Figure - apidra 23

Figure - apidra 24

Figure - apidra 24

Figure - apidra 25

Figure - apidra 25

PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton - apidra 26

PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton - apidra 26

This is a medication called Apidra® which contains insulin glulisine for injection. Each mL has 100 IU of insulin glulisine, along with other ingredients. The package insert contains information about dosage and administration. The medication should be used cautiously and only under medical supervision. An unopened Apidra® vial should be stored refrigerated and discarded after 28 days if left at room temperature. The opened vials can be kept unrefrigerated for up to 28 days. The manufacturer is sanofi-aventis U.S. LLC. The text also includes a warning to keep the medication out of reach of children, and a GTIN number.*

PRINCIPAL DISPLAY PANEL - 3 mL Pen Carton - apidra 27

PRINCIPAL DISPLAY PANEL - 3 mL Pen Carton - apidra 27

This is a description of a medical product by Sanofi for insulin glulisine injection in a disposable insulin delivery device. The product comes in a sealed carton containing five 3 mL prefilled pens and is for subcutaneous injection only. It is important to use the solution only if it is clear and colorless with no visible particles, and to use within 28 days after initial use. The product does not include needles.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.